Navigation Links
Merz Pharmaceuticals Receives J-Code For Xeomin® (incobotulinumtoxinA)
Date:1/4/2012

GREENSBORO, N.C., Jan. 4, 2012 /PRNewswire/ -- Merz Pharmaceuticals, LLC, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific Healthcare Common Procedure Coding System (HCPCS) billing code, J0588 "INJECTION, INCOBOTULINUMTOXIN A, 1 UNIT" for Xeomin® (incobotulinumtoxinA), effective beginning January 1, 2012.

The U.S. Food and Drug Administration (FDA) approved XEOMIN in July 2010 for the treatment of cervical dystonia in adults, to decrease the severity of abnormal head position and neck pain in both botulinum toxin-naive and previously treated patients, and blepharospasm in adults who have been previously treated with Botox® (onabotulinumtoxinA).

"We are so pleased that CMS granted a permanent product-specific code for XEOMIN," said Janet Hieshetter, Executive Director of the Dystonia Medical Research Foundation (DMRF). "This milestone reinforces the importance of ensuring access to all available treatment options. The DMRF congratulates Merz on this achievement and applauds their ongoing dedication to patient and physician support."

Merz is committed to supporting patients and physicians in the cervical dystonia and blepharospasm community. In addition to offering services such as the industry-leading Co-pay Assistance Program, which helps alleviate patient out-of-pocket expenses, XEOMIN's list price has been reduced by nearly 20 percent, effective October 6, 2011, in an effort to ensure access to therapy for the greatest number of patients.

XEOMIN is the only botulinum neurotoxin that requires no refrigeration prior to reconstitution and can be stored at room temperature for up to 36 months. XEOMIN is also the only type A botulinum neurotoxin that is available in 50-unit single use vials that may allow for a reduction in wastage and may minimize patient out-of-pocket expenses.

"This is a
'/>"/>

SOURCE Merz Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Quark Pharmaceuticals Reports Favorable Interim Results from Phase I Clinical Study of QPI-1007 in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
2. Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy
3. Auxilium Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
4. MAP Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
5. Jazz Pharmaceuticals to Hold Investor Conference Call on January 5 to Discuss 2012 Financial Guidance and Azur Pharma Transaction
6. Radient Pharmaceuticals Announces Reverse Stock Split
7. Idenix Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
8. Optimer Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
9. Optimer Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
10. Endo Pharmaceuticals to Present at J.P. Morgan 30th Annual Healthcare Conference
11. Provenance Biopharmaceuticals Corp. Announces $8M Financing Arrangement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... , Nov. 21, 2014  CytoSorbents Corporation ... its European Union approved CytoSorb® cytokine adsorber to ... awarded the Beacon of Light Award at last ... Dr. Phillip Chan , ... an honor to be recognized by the New ...
(Date:11/22/2014)... Statistics released from a number of organizations show that ... holidays, beginning with Thanksgiving eve, which is now termed ... data, highlighted in an Infographic released by ... annual Sober Days for the Holidays public awareness ... increased rates of DUI injuries and deaths during the ...
(Date:11/22/2014)... -- Research and Markets  has announced the addition of ... report to their offering. ... drug market has been expanding rapidly owing to the ... During 2005-2013, sales of recombinant protein drugs available in ... and it is projected that China ...
Breaking Medicine Technology:CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4Alarming Stats Show Holiday Drinking an Issue for Many 2China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3
... DUBLIN, October 18, 2010 ... ... --> ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
... the PRECiSE 3 (P3) open label extension study for ... maintenance trial for an anti-TNF in Crohn,s disease, will ... the American College of Gastroenterology (ACG), taking place in ... efficacy data from the PRECiSE 4 (P4) clinical trial ...
Cached Medicine Technology:Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 2Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 3Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 4Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 5Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 6Shire plc: Third Quarter 2010 Results Date Notification - October 29, 2010 7UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 2UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 3UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 4UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 5UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 6UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 7UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 8UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 9UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 10UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohn's Disease 11
(Date:11/23/2014)... 2014 Locks-Magnetic.com, a notable magnetic locks ... all the new products are available at low rates ... is proud of the new emergency doors. The emergency ... customers can choose from several colors. All of the ... emergency door release is not as easy as many ...
(Date:11/23/2014)... 23, 2014 More than two dozen ... a federal litigation involving Byetta lawsuits ( http://www.byettalawsuit2013.com/ ), ... Liebhard LLP reports. , A Case List updated ... class of Type 2 diabetes medications referred to as ... District Court, Southern District of California, where a federal ...
(Date:11/23/2014)... Church, VA (PRWEB) November 23, 2014 ... TV Have in Common, **FDAnews On-Demand Webinar**, Dec. 11, ... http://www.fdanews.com/TheFDAisWatchingOnDemand , The FDA’s focus on promotional activities ... , Now they're looking at websites, Twitter, ... Mark the calendar for Thursday, Dec. 11, for On-Demand ...
(Date:11/23/2014)... Salt Lake City, Utah (PRWEB) November 23, 2014 ... in individual health insurance reimbursement for small businesses, ... the new book, The End of Employer-Provided Health ... employer-provided health insurance is the greatest financial risk ... greatest challenge facing U.S. employers, small and large, ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 PrettyTailor ... website with a new big promotion. Customers can buy ... detailed information, customers can visit its website. , As ... apparel and occasion dresses. It mainly provides four types ... bride dresses and flower girl dresses. It also provides ...
Breaking Medicine News(10 mins):Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 2Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 3Health News:California Federal Court Overseeing Byetta Lawsuits, Other Incretin Mimetic Claims Adds New Cases in November, Bernstein Liebhard LLP Reports 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2
... , ... proceeds from its sales to facilitate a speedy recovery from one of the world’s worst ... established to help in the rebuilding of Haiti. MBMI hopes that this initiative will inspire ... ...
... blood test in office, not home tests , THURSDAY, ... proper use of a colorectal cancer screening method called the ... from the U.S. Centers for Disease Control and Prevention surveyed ... them order or perform an in-office fecal occult blood test ...
... researchers from Georgetown University,s Institute for Reproductive Health to ... by a growing number of women to help plan ... wish to become pregnant are unsuccessful because they do ... American Infertility Association. CycleBeads is a fertility management aid ...
... ... for Healthcare Conference, taking place in Houston, TX April 19, 20 and 21, 2010. ... session, "Next Practices" and Best Practices in Learning and Development at Kaiser Permanente. ... Cambridge, MA ...
... more minutes to fall asleep , THURSDAY, April 15 (HealthDay ... well if he indulges in a violent video game right before ... teens who played the popular video game "Call of Duty 4: ... who watched a documentary. , A report on the finding appears ...
... ... celebrating a one-of-a-kind event with the Grand Opening of its new location in ... author Jacqueline Wilson, will be spilling the best kept dog training secrets and ... pet services and products. Guests and their pets will enjoy gourmet foods and ...
Cached Medicine News:Health News:MBMI Steel Buildings is Saving Haiti One Building at a Time 2Health News:Many Doctors Not Using Colon Cancer Test Properly 2Health News:Getting the bead on conception 2Health News:Getting the bead on conception 3Health News:Interaction Associates to Sponsor HCI Talent Management for Health Care Conference 2Health News:Interaction Associates to Sponsor HCI Talent Management for Health Care Conference 3Health News:Video Games Before Bed May Not Shortchange Slumber 2Health News:Video Games Before Bed May Not Shortchange Slumber 3Health News:Shi Shi Pet Boutique's Open House Happy Hour Benefiting 'Brooke's Lucky Dog Rescue' Saturday April 24, 2010 4:00pm - 8:00pm 2
Each handle is designed to fit a specific trephine size....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Reusable, stainless steel trephine with handle....
Medicine Products: